Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Chief Commercial Officer

President and CEO

Chief Scientific Officer

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. Milestone Pharmaceuticals Inc. has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in MontrÃƒÂ©al, Canada.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines....

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-03-22	Premium	sold	Premium	Premium	Premium	-
2022-12-05	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2022-12-01	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2022-10-21	Premium	bought	Premium	Premium	Premium	-
2022-10-20	Premium	bought	Premium	Premium	Premium	-
2022-10-20	Premium	bought	Premium	Premium	Premium	-
2022-10-19	Premium	bought	Premium	Premium	Premium	-
2022-10-19	Premium	bought	Premium	Premium	Premium	-
2022-09-14	Premium	acquired	Premium	Premium	Premium	-
2022-09-07	Premium	bought	Premium	Premium	Premium	-
2022-09-07	Premium	sold	Premium	Premium	Premium	-
2022-05-31	Premium	acquired	Premium	Premium	Premium	-
2022-05-31	Premium	bought	Premium	Premium	Premium	-
2020-08-26	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2020-07-29	Premium	sold	Premium	Premium	Premium	-
2020-07-28	Premium	sold	Premium	Premium	Premium	-
2020-04-03	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2020-03-19	Premium	bought	Premium	Premium	Premium	-
2020-03-18	Premium	bought	Premium	Premium	Premium	-
2020-03-02	Premium	bought	Premium	Premium	Premium	-
2020-01-13	Premium	bought	Premium	Premium	Premium	-
2019-12-31	Premium	bought	Premium	Premium	Premium	-
2019-12-30	Premium	bought	Premium	Premium	Premium	-
2019-12-21	Premium	acquired	Premium	Premium	Premium	President and CEO
2019-11-25	Premium	sold	Premium	Premium	Premium	-

MIST - Milestone Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for MIST